Abstract:Background: Gram-negative bacilli are one of the most common causes of various infections in clinical. The emergence and global spread of multi-drug resistant gram-negative bacilli has become a major challenge in the global public health field. Methods: A total of 51,189 non-repetitive strains of gram-negative bacilli were isolated in clinical settings. The antimicrobial susceptibility testing was conducted by using the automated VITEK 2 compact system and the matched AST susceptibility test card, complemented by the disk diffusion method. The antimicrobial susceptibility results were interpreted by CLSI. Rates of MDR and XDR in Klebsiella pneumoniae , Acinetobacter baumannii , and Pseudomonas aeruginosa were investigated. Used the chi-square test to determine whether the antimicrobial resistance rates of four major gram-negative bacilli isolated from ICU and non-ICU department have statistical differences. Results: Escherichia coli (31.4%), Klebsiella spp. (21.2%), Acinetobacter spp. (13.8%), and P. aeruginosa (11.0%) were the most frequently isolated gram-negative bacilli. Escherichia coli was the top one organism isolated from urinary tract (68.4%), bloodstream (39.9%), body fluid (33.2%), wound and pus (37%), except for respiratory tract (8.8%). Whereas Acinetobacter baumannii and K. pneumoniae were the major isolated organisms from respiratory tract. Acinetobacter baumannii showed high resistance to fluoroquinolones, β-lactam/β-lactamase inhibitor combinations class, ceftazidime, cefepime, imipenem, and meropenem, the resistance rates reached more than 70%. Ceftazidime showed a lower resistance rate to E. coli than ceftriaxone. For E. coli , fluoroquinolones showed a high resistance rate (ciprofloxacin 61.36% and levofloxacin 53.97%), whereas amikacin, carbapenems exhibited a lower resistance rate fluctuating at 2%. Acinetobacter baumannii and K. pneumoniae showed rapid increases in carbapenem resistance whereas E. coli had the lowest resistance rate and remain stable at 2%. Acinetobacter baumannii exhibited the highest rate of MDR and XDR, reaching 60–80 and 45–55%, respectively. Compared to non-ICU departments, the resistance rates of four major gram-negative bacilli in the ICU department were much higher and the differences were statistically significant ( p < 0.05). Conclusion: Amikacin, carbapenems, and piperacillin/tazobactam exhibited relatively high sensitivity, whereas fluoroquinolones showed high resistance rate whether they can be the first-line antimicrobials for empirical treatment of UTI should take more consideration. The gram-negative bacilli in ICU were more resistance than that in non-ICU. These findings are helpful for clinicians using antimicrobials reasonably.

Surveillance of Antimicrobial Resistance among Gram-Negative Bacilli from Intensive Care Unit

[Surveillance of Antimicrobial Resistance among Nosocomial Gram-Negative Pathogens from 15 Teaching Hospitals in China in 2005].

Surveillance of antibiotic resistance in clinical isolates from First Affiliated Hospital of Zhejiang University Medical College in 2009

Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013

Study on the antibacterial activity of three carbapenems to the strains isolated from ICU

Changes of Pathogens and Antimicrobial Resistance of Nonfermenting Gram-negative Bacilli in Intensive Care Unit

Mohnarin Report of 2011: Monitoring of Bcterial Resistance Intensive Care Unit

Surveillance of antimicrobial resistance among clinical isolates from intensive care units in tertiary hospital, 2012

Mohnarin Report of 2010:Monitoring of Bacterial Resistance in Intensive Care Units

Mohnarin Report of 2010 :Surveillance of Bacterial Resistance of Non-Icu Inpatients

Resistance Surveillance of 400 Gram-negative Bacterial Isolates from Intensive Care Unit with E-test

Distribution and antimicrobial resistance analysis of gram-negative bacilli isolated from a tertiary hospital in Central China: a 10-year retrospective study from 2012 to 2021

Surveillances of Pathogens Distribution and Antibiotic Resistance in General Intensive Care Unit

Mohnarin report of 2011:monitoring of bacterial resistance of non-ICU inpatients

Ministry of Health National Antimicrobial Resistance Investigation Net Annual Report of 2011: Surveillance of Antimicrobial Resistance in Bacteria from Intensive Care Units

Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002.

Drug Resistance Investigation of Lower Respiratory Tract Infection with Gram-negative Bacilli in ICU

Mohnarin Annual Report 2010 :Surveillance of Antimicrobial Resistance in Bacteria Isolated from Intensive Care Units

Study on Antimicrobial Resistance and Detection of AmpC and Extended-Spectrum Β-Lactamases-producing Strains in a Respiratory Intensive Care Unit

[Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000 - 2001)]

Comparison of antimicrobial activity in vitro of 7 β-lactams against 280 isolates from patients with nosocomial infections